Business
Expeditors provides air and ocean freight forwarding, customs brokerage and logistics services.
Expeditors converted modest logistics growth into higher profit and free cash flow, while completing remediation of previously reported control weaknesses.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 4.4%OK
- Profitability — Net income grew 0.0% to $810.332M from $810.073MOK
- Cash flow — Free cash flow grew 39.6% to $953.4M from $682.895MOK
- Margins — Operating margin contracted 31 bps to 9.51%Watch
- Accounting — Strong asset-light cash flow and remediated controlsNote
- Insiders — 0 purchases and 8 salesNote
Where the revenue comes from
Fiscal 2025, as EXPEDITORS INTERNATIONAL OF WASHINGTON INC reports it. History and quarterly detail are in the app.
- Customs Brokerage And Other Services$4.3B
- Airfreight Services$4.0B
- Ocean Freight And Ocean Services$2.8B
Leadership changes
From EXPEDITORS INTERNATIONAL OF WASHINGTON INC's own filings, the day they're filed.
- David A. Hackett · President · appointmenteff. 2025-09-30
- Kelly K. Blacker · President · appointmenteff. 2025-04-01
- Daniel R. Wall · President · appointmenteff. 2025-04-01
Latest filings
- 8-K · Company announcement2026-08-11
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-08-04
- 8-K · Company announcement2026-05-20
- 8-K · Company announcement2026-05-06
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about EXPEDITORS INTERNATIONAL OF WASHINGTON INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.